Table 2.
Markers of exercise tolerance compared between amiloride and placebo trials
| n | Placebo | Amiloride | Mean Diff | 95% CI | ηp2 | P | |
|---|---|---|---|---|---|---|---|
| Time to failure, s | 10 | 570.1 ± 255.0 | 639.6 ± 264.1 | 69.4 ± 63.2* | 30.3/108.6 | 0.573 | <0.01 |
| Time tension index, kg·s/1,000a | 10 | 6.72 ± 4.31 | 8.16 ± 5.68 | 1.44 ± 0.63* | −361.0/3244.2 | 0.496 | 0.02 |
| Pain, cm | 10 | 3.1 ± 2.5 | 3.5 ± 3.2 | 0.4 ± 1.7 | −1.5/0.6 | 0.06 | 0.46 |
| RPE | 10 | 16 ± 2 | 16 ± 2 | 0 ± 0 | 0/0 | 0.18 | 0.19 |
Data are means ± SD for placebo, amiloride, and mean diff; n, number of participants.
aDifferences in assigned contraction intensity included as covariate. Mean diff, mean difference; ηp2, partial η squared; RPE, rating of perceived exertion. *Significant difference between conditions.